Shih-Chao Kang, Shinn-Jang Hwang, Yu-Sheng Chang, Chung-Tei Chou, Chang-Youh Tsai 8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. 9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725. 10. Special Medical Needs, Bureau of National Health Insurance, Department of Health, Executive Yuan, Republic of China (Taiwan), 2012. Available at: http://www.nhi.gov.tw/english/index.aspx. 11. Chiu YM, Lai CH. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 2010; 19: 1250-5. 12. Wang TF, Lin HC. Relationship between caseload volume and outcome for systemic lupus erythematosus treatment: the experience of Taiwan. J Rheumatol 2008; 35: 1795-800. 13. National Health Insurance Research Database, National Health Research Institutes, Republic of China (Taiwan), 2012. Available at: http://w3.nhri.org.tw/nhird/en/index.htm. 14. Pelletier EM, Ogale S, Yu E, et al. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database. Clin Ther 2009; 31: 2653-64. 15. Lin WY, Chiu TY, Hsu HS, et al. Medical expenditure and family satisfaction between hospice and general care in terminal cancer patients in Taiwan. J Formos Med Assoc 2009; 108: 794-802. 16. Paz-Ruiz S, Gomez-Batiste X, Espinosa J, et al. The costs and savings of a regional public palliative care program: the Catalan experience at 18 years. J Pain Symptom Manage 2009; 38: 87-96. 17. Bendaly EA, Groves J, Juliar B, et al. Financial impact of palliative care consultation in a public hospital. J Palliat Med 2008; 11: 1304-8. 18. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995; 22: 1259-64. 19. Gulay CB, Dans LF. Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus. Pediatr Rheumatol Online J 2011; 9: 7. 20. Mok C. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 2011; 27: 767-71. 21. Feng PH, Lin SM, Yu CT, et al. Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit. Am J Med Sci 2010; 340: 64-8. 22. Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in systemic lupus erythematosus. Ethn Dis 2009; 19: 301-7. 23. Clarke AE, Panopalis P, Petri M, et al. SLE patients with renal damage incur higher health care costs. Rheumatology (Oxford) 2008; 47: 329-33. 24. Mok CC, Poon WL, Lai JP, et al. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Scand J Rheumatol 2010; 39: 42-9. 25. Hak AE, Karlson EW, Feskanich D, et al. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum 2009; 61: 1396-402. 26. Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 2010; 27: 636-43. 27. Lin HC, Lin YJ, Liu TC, et al. Urbanization and stroke prevalence in Taiwan: analysis of a nationwide survey. J Urban Health 2007; 84: 604-14. 28. Huang ZS, Chiang TL, Lee TK. Stroke prevalence in Taiwan. Findings from the 1994 National Health Interview Survey. Stroke 1997; 28: 1579-84. 29. Wang KT, Chen CY, Hou CJ, et al. Comparison of clinical characteristics of acute myocardial infarction in aborigines and nonaborigines in Taitung area of Taiwan. Angiology 2007; 58: 61-6. 30. Hiraki LT, Benseler SM, Tyrrell PN, et al. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009; 36: 2539-46. 31. Korbet SM, Schwartz MM, Evans J, et al. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-54. 32. Zhou WJ, Yang CD. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients. Lupus 2009; 18: 807-12. 33. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1481-90. 34. Kang KY, Kim HO, Yoon HS, et al. Incidence of cancer among female patients with systemic lupus erythe- matosus in Korea. Clin Rheumatol 2010; 29: 381-8. 35. Chen YJ, Chang YT, Wang CB, et al. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 2010; 123: 1150.e1-6. 696 Arch Med Sci 4, August / 2012